http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-059007-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 |
| filingDate | 2007-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-059007-A1 |
| titleOfInvention | USE OF A PHARMACEUTICALLY EFFECTIVE AMOUNT OF MEMENTINE FOR THE PREPARATION OF A MEDICINAL PRODUCT |
| abstract | Use of a pharmaceutically effective amount of memantine or a salt thereof for the preparation of a medicament useful for the treatment of visual function disorders. Administration may be local to the eye or in the form of an injection or orally. The medication can be liquid, in the form of an ophthalmic solution, in a concentration of 0.01 to 2.0 percent (P / V). Such visual function disturbances may be the result of an injury to the outer retina that causes a deficit of visual acuity. As a result, an improvement is obtained in a reading of the Snellen Eye Graph of at least one line. |
| priorityDate | 2006-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4054 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505100 |
Total number of triples: 13.